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NAFLD (non-alcoholic fatty liver disease), associated with
obesity and the cardiometabolic syndrome, is an important
medical problem affecting up to 20% of western populations.
Evidence indicates that mitochondrial dysfunction plays a critical
role in NAFLD initiation and progression to the more serious
condition of NASH (non-alcoholic steatohepatitis). Herein we
hypothesize that mitochondrial defects induced by exposure to
a HFD (high fat diet) contribute to a hypoxic state in liver
and this is associated with increased protein modiﬁcation by
RNS (reactive nitrogen species). To test this concept, C57BL/6
mice were pair-fed a control diet and HFD containing 35% and
71% total calories (1 cal≈4.184 J) from fat respectively, for
8 or 16 weeks and liver hypoxia, mitochondrial bioenergetics,
NO (nitric oxide)-dependent control of respiration, and 3-NT (3-
nitrotyrosine), a marker of protein modiﬁcation by RNS, were
examined. Feeding a HFD for 16 weeks induced NASH-like
pathology accompanied by elevated triacylglycerols, increased
CYP2E1 (cytochrome P450 2E1) and iNOS (inducible nitric
oxide synthase) protein, and signiﬁcantly enhanced hypoxia in
the pericentral region of the liver. Mitochondria from the HFD
group showed increased sensitivity to NO-dependent inhibition
of respiration compared with controls. In addition, accumulation
of 3-NT paralleled the hypoxia gradient in vivo and 3-NT levels
were increased in mitochondrial proteins. Liver mitochondria
from mice fed the HFD for 16 weeks exhibited depressed
state 3 respiration, uncoupled respiration, cytochrome c oxidase
activity, and mitochondrial membrane potential. These ﬁndings
indicate that chronic exposure to a HFD negatively affects the
bioenergetics of liver mitochondria and this probably contributes
to hypoxic stress and deleterious NO-dependent modiﬁcation of
mitochondrial proteins.
Key words: cytochrome c oxidase, hypoxia, liver, mitochondria,
nitric oxide, non-alcoholic steatohepatitis.
INTRODUCTION
NAFLD (non-alcoholic fatty liver disease), a key component
of the cardiometabolic syndrome, has emerged as one of the
most common aetiologies of chronic liver disease. NAFLD
can progress from simple fatty liver (i.e. steatosis) to more
severe conditions such as NASH (non-alcoholic steatohepatitis),
and cirrhosis, if left untreated. Estimates place the prevalence
of NAFLD in the general U.S.A. population at 20%, with
the more severe form, NASH, present at 3–5% [1,2]. Even
more startling is the fact that NAFLD is present in pediatric
populations,withprevalenceestimatedat2–10%amongchildren
and adolescents in the U.S.A. and Asian countries [3]. NASH
is characterized histologically by macrosteatosis, inﬂammation,
hepatocyte ballooning, and pericellular ﬁbrosis in zone 3 of the
liver lobule. Insulin resistance, disrupted fatty acid metabolism,
mitochondrial dysfunction, oxidative stress and dysregulation
of adipocytokine networks are proposed to be critical factors
in the development of NASH. The interaction between these
factors is, however, not well understood, which has slowed
progress in developing a clear molecular understanding of NASH
pathogenesis. In this study, we propose that a loss in control over
the regulation of oxygen supply and demand in the liver may be
a major contributory factor for the initiation and progression of
this complex disease pathology.
The concept that hypoxia may play a critical role in the
aetiology of liver diseases is well established in other pathologies
associated with steatosis. For example, Arteel et al. [4,5]
demonstrated that chronic and acute alcohol exposure causes
hypoxia in the pericentral region of the liver presumably due to
increased O2 consumption in response to alcohol metabolism and
through the release of vasoconstrictive eicosanoids from Kupffer
cells. More recently, chronic hypoxia has been implicated as a
contributing factor in liver injury in response to obstructive sleep
apnea [6], which has also been linked to the cardiometabolic
syndrome and NASH [7]. Savransky et al. [6] found that chronic
intermittent hypoxia in combination with a HFD (high fat
diet) induces inﬂammation and lipid peroxidation in mice, with
increased steatosis observed in the hypoxia exposure group. In
the present study, it was hypothesized that the interaction of
hypoxia with secondary insults or ‘stressors’ such as a HFD may
beresponsiblefortheprogressionfromsimplesteatosistoNASH.
What has not been examined, however, is whether exposure to
a HFD alone is sufﬁcient to induce liver injury, mitochondrial
dysfunction, and hypoxia without the additional stressor of whole
body O2 deprivation.
Currently, NASH pathogenesis is proposed to occur in res-
ponse to fat accumulation in hepatocytes coupled with mitochon-
drial dysfunction, which may be manifested by disrupted fatty
acid oxidation, depressed bioenergetics and increased oxidative
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stress arising from enhanced generation of ROS (reactive oxygen
species) and RNS (reactive nitrogen species) [8]. Indeed, one
key functional change to liver mitochondria in animal models
of obesity-induced fatty liver disease is the inability to
maintain sufﬁcient ATP levels. This may result from impaired
electron transport and/or increased proton leak across the
inner mitochondrial membrane, which dissipates the membrane
potential and decreases the capacity for ATP synthesis [9].
Hepatic mitochondria of NASH patients exhibit para-crystalline
inclusions in mega-mitochondria [10], increased mtDNA
(mitochondrial DNA) mutations [11] and lower respiratory
complex activities [12]. Studies show that alcohol-induced fatty
liver disease is also associated with depressed activity of the
respiratory chain via damage to the mtDNA and ribosomes
[13,14]. Moreover, we have found alcohol-dependent changes
in the mitochondrial proteome [15] and alterations in NO (nitric
oxide) signalling in the mitochondrion [16,17]. A role for NO
in controlling O2 gradients within tissues and the response to
hypoxia has been proposed [18,19]. These mechanisms appear
to involve the interaction of NO with mitochondria, and in
both the hypoxic stress associated with cardiac failure and
alcohol-dependent steatosis, the respiratory chain becomes more
sensitive to NO [16,20]. Speciﬁcally, NO-dependent inhibition
of hepatic mitochondrial respiration is increased following
chronicalcoholconsumption[16,17],whereasalterationsinmito-
chondrial sensitivity to NO have not been examined in NAFLD
or NASH.
Taken together, the results support the hypothesis that defects
in mitochondrial bioenergetics play a key role in the progression
from simple steatosis to the more severe condition of NASH.
Herein,weproposethatmitochondrialdysfunction,hypoxicstress
and increased protein modiﬁcations due to increased ROS and
RNS are linked and contribute to the pathophysiology of NASH.
Inthepresentstudy,wetestedthishypothesisbyfeedingC57BL/6
mice a HFD for 8 or 16 weeks and examined the bioenergetics
of liver mitochondria and extent of liver hypoxia. Accordingly,
studies were undertaken to determine whether the responsiveness
of mitochondrial respiration to inhibition by NO was altered by
chronic exposure to a HFD.
EXPERIMENTAL
Materials
Chemicals were of the highest quality available and purchased
from Sigma–Aldrich unless stated otherwise. PROLI NONOate
and PAPA NONOate [1-propanamine, 3-(2-hydroxy-2-nitroso-
1-propylhydrazino)] were obtained from Alexis Biochemicals,
pimonidazole hydrochloride was from Chemicon International,
and JC-1 (5,5
 ,6,6
 -tetrachloro-1,1
 ,3,3
 -tetraethylbenzimidazol
carbo-cyanineiodide)fromInvitrogen.ControldietsandtheHFD
were purchased from Dyets (Bethlehem, PA, U.S.A.).
Dietary feeding protocol
Male C57BL/6 mice (8 weeks old) were purchased from Jackson
Laboratories (Bar Harbor, ME,U.S.A.) andfed aHFD containing
71% total calories (1 cal≈4.184 J) as fat, 11% as carbohydrate,
and 18% as protein [21]. The control diet contained 35% total
calories as fat, 47% as carbohydrate, and 18% as protein. The
control diet and HFD are nutritionally adequate, caloriﬁcally
equivalent (1 kcal/ml), and contain equal amounts of fat as olive
and safﬂower oil with excess corn oil added to the HFD. Mice
were maintained on diets for 8 or 16 weeks and handled in
accordance with recommendations in the ‘Guide for the Care
and Use of Laboratory Animals’ (NIH publication 86-23 revised
1985). These studies were approved by the UAB Institutional
Animal Care and Use Committee. Animals were anaesthetized
for liver perfusion procedures using a 50 mg/kg (intraperitoneal)
dose of sodium pentobarbital. Animals were monitored daily and
weighed weekly, and they showed no pain or distress during the
feeding regimen or the experimental procedures.
Liver histology and triacylglycerol measurements
Formalin-ﬁxed liver samples were processed for heamatoxylin-
eosin staining and evaluated for steatosis, hepatocyte ballooning,
and Mallory bodies by a hepatologist that was blind to the
experiment. Triacylglycerol content was measured in liver
homogenatesusingthetriacylglycerol-GPOreagentsetkit(Pointe
Scientiﬁc, Canton, MI, U.S.A.) according to the manufacturer’s
instructions.
Immunohistochemistry for pimonidazole and 3-NT (3-nitrotyrosine)
Liver hypoxia was assessed using the hypoxia marker pimoni-
dazole [4]. Mice were injected with pimonidazole (60 mg/kg
in saline, intraperitoneal) and after 1 h, blood and unbound
pimonidazole were cleared from the liver by perfusion with
warm Gey’s Balanced Salt solution. Livers were harvested
and processed for immunohistochemistry. Formalin-ﬁxed liver
sections were deparafﬁnized in xylene and rehydrated through
incubations in graded ethanol concentrations. Sections were
blockedfor10 minwith5%(w/v)BSAinaTBS-T(Tris-buffered
saline/Tween 20) solution and incubated with pimonidazole-
1MAb1 conjugated with FITC (1:50 dilution) for 1 h. After
washes, slides were incubated for 1 h with anti-FITC conjugated
with HRP (horseradish peroxidase), and bound antibody was
visualizedwithDAB(diaminobenzidine)chromagenfollowedby
counterstainingwithhaematoxylin.Positivepimonidazoleprotein
adductstainingwasvisualizedbybrownstaining,andtheareaand
intensity of staining were quantiﬁed using Simple PCI software
(Hamamatsu Corporation, Sewickley, PA, U.S.A.).
Immunohistochemistry for 3-NT was performed essentially as
described above and in [17]. Deparafﬁnized and rehydrated liver
sections were subjected to antigen retrieval in 10 mM citrate
buffer, pH 6.0. Endogenous peroxidase activity was quenched
by immersion of the slides in 3% (v/v) H2O2 for 10 min, and
tissues were blocked for 1 h at room temperature (25◦C) with
10% (v/v) goat serum in a 1% (w/v) BSA/TBS-T solution.
Sections were incubated for 2 h at room temperature in a humi-
diﬁed chamber with rabbit polyclonal 3-NT antibody (a gift
from Dr. Alvaro Estevez, Weill Medical College of Cornell
University, Ithaca, NY, U.S.A.) at a 1:150 dilution. Following
incubation, tissues were washed in TBS-T and incubated with
secondary antibody at a 1:200 dilution and bound antibody
was visualized with DAB chromagen. Quantiﬁcation for 3-NT
staining was done as described for pimonidazole protein adduct
immunohistochemistry.
Immunoﬂuorescence for iNOS (inducible nitric oxide synthase)
Levels of iNOS protein in liver were assessed by immuno-
ﬂuorescenceasdescribedin[17]withthefollowingmodiﬁcations.
OCT-embedded frozen liver sections were ﬁxed in ice-cold
acetonefor5 minfollowedbyblockingin2%(w/v)BSAsolution
in PBS for 1 h at room temperature. After washes with PBS,
tissues were incubated overnight at 4◦C with rabbit polyclonal
iNOS antibody (Chemicon International, Temecula, CA, U.S.A.)
diluted 1:150. Following incubation, tissues were washed in PBS
andincubatedwithgoatanti-rabbitAlexaFluor® 594(Invitrogen,
Eugene, OR, U.S.A.) for 1 h at room temperature. Sections
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were washed with PBS and mounted using VECTASHIELD®
mounting medium with DAPI (4
 ,6-diamidino-2-phenylindole;
Vector Labs) to visualize nuclei. Images were taken and analysed
using a Leica ﬂuorescent microscope with IPLAB Spectrum (BD
Biosciences Bioimaging, Scanalytics, Rockville, MD, U.S.A.)
with the intensity of ﬂuorescence quantiﬁed as described for
immunohistochemistry.
Immunoblotting for CYP2E1 (cytochrome P450 2E1) protein and
3-NT in mitochondrial proteins
CYP2E1 protein levels were measured by immunoblotting using
1:1000 dilution of anti-CYP2E1 antibody (Chemicon Inter-
national) followed by 1:10000 dilution of secondary antibody.
Levels of 3-NT in mitochondrial proteins were measured using
a 1:1000 dilution of anti-nitrotyrosine antibody (Upstate, Lake
Placid, NY, U.S.A.) followed by 1:10000 dilution of secondary
antibody.Proteinbandswerevisualizedusingchemiluminescence
detection. Immunoreactive protein bands and total protein on
duplicate stained gels were quantiﬁed using Quantity One image
analysis software (Bio-Rad, Hercules, CA, U.S.A.).
Preparation of liver mitochondria and respiration measurements
Coupled liver mitochondria were prepared by differential centri-
fugationofliverhomogenates[15]usinganice-coldmitochondria
isolation medium containing 250 mM sucrose, 1 mM EDTA and
5 mM Tris/HCl, pH 7.5. Protease inhibitors were added to the
isolation buffer to prevent protein degradation. Respiration rates
were measured using a Clark-type O2 electrode as described
previously[15].Mitochondriawereincubatedinrespirationbuffer
containing 130 mM KCl, 3 mM Hepes, 1 mM EGTA, 2 mM
MgCl2 and 2 mM KH2PO4, pH 7.2. State 3 and 4 respiration
rates and the RCR (respiratory control ratio, calculated as the
ratio of state 3 to state 4 respiration rates) were measured with
the oxidizable substrates succinate/rotenone (15 mM/5 μM) or
glutamate/malate (5 mM each), and ADP (0.5 mM) was added
to initiate state 3 respiration. Uncoupler-stimulated respiration
was measured in the presence of FCCP (carbonyl cyanide p-
triﬂuoromethoxyphenylhydrazone) (1 μM).
Mitochondrial respiratory complex activities and membrane
potential measurements
Cytochrome c oxidase activity was measured using a standard
spectrophotometric method [22], which monitors oxidation of
ferrocytochrome c at 550 nm. Complex I activity (i.e. NADH
dehydrogenase) was determined by measuring the rotenone-
sensitive rate of oxidation of NADH initiated by coenzyme Q1
[23], and citrate synthase activity was measured as described in
[15].
JC-1isacationicdyethataccumulateswithinthemitochondrial
matrixandisusedtoassessalterationsinmembranepotential[24].
Inthepresenceofahighnegativemembranepotential,JC-1forms
red ﬂuorescent aggregates (emission 590 nm), whereas under
depolarized conditions it exists as green monomers (emission
530 nm). Mitochondria (0.5 mg/ml) were incubated with 2 μM
JC-1inrespirationbufferwithandwithout1 μMFCCPfor20 min
at 37◦C, and the red/green ﬂuorescence ratio was determined.
NO-dependent control of respiration
The effect of exogenous NO on mitochondrial respiration was
investigated using a closed dual-chamber oxygraph respirometer
(Oroboros, Innsbruck, Austria) with chamber stoppers modiﬁed
to house a NO sensor (ISO-NOP, World Precision Instruments,
Sarasota, FL, U.S.A.) for simultaneous measurement of O2 and
NOconcentrations[25].TheO2 sensorsignal,calibratedin100%
air-equilibrated respiration buffer, was converted into μMb yt h e
OroborosDatLabsoftwareusingtheO2 solubilityofthebufferand
the daily barometric pressure. The NO sensor was calibrated with
the fast releasing NO donor PROLI NONOate (t1/2=1.3 s) over
a concentration range of 1.25–5.0 μMa tl o wO 2 levels. Sensor
signal in nA was recorded with a free radical analyser (Apollo
4000, WPI, Sarasota, FL, U.S.A.) and converted into μMN O
using the generated NO calibration curve.
Mitochondria (0.5 mg/ml) were injected into air-equilibrated
respiration buffer (∼200 μMO 2), and succinate/rotenone
(15 mM/5 μM) and ADP (0.5 mM) were added to initiate state 3
respiration. After a stable baseline respiration rate was obtained,
the NO donor PAPA NONOate (5 μM, t1/2=15 min) was added
at 160 μMO 2 (∼80% O2 saturation), which resulted in NO
releaseandaprogressiveinhibitionofrespiration(seeFigure5A).
NO traces were corrected for baseline and aligned with the
corresponding O2 traces in order to plot O2 consumption rates,
calculated as derivatives of the O2 concentration against time
traces, and normalized to the maximum respiration rate as a
function of NO concentration (see Figure 5B) [16].
Statistics
Values are reported as means+ −S.E.M. for 3–6 animals per
group. Signiﬁcant differences (P<0.05) between control and
HFD groups were obtained using Student’s paired t test.
RESULTS
Feeding a HFD causes NASH
MicewerefedacontroldietorHFDinapair-fedisocaloricfashion
for 8 or 16 weeks. Livers from mice on the control diet exhibited
no pathology (Figure 1A). These ﬁndings are in agreement
with those from previous studies conducted by our laboratories
using the same control liquid diet [17]. In contrast, livers
from mice fed a HFD showed an accumulation of macro-
and micro-vesicular fat at both the 8 (results not shown) and
16 week time points (Figure 1B), which was associated with
increased liver triacylglycerol content (Figure 1D) and CYP2E1
protein (Figure 1E) as compared with controls. Steatosis was
accompanied by hepatocyte ballooning and Mallory bodies in
zone3oftheliverlobule(Figure1C),whicharehallmarkfeatures
of NASH. These results are consistent with earlier observations
from Lieber et al. [21], who reported the development of NASH-
like features in rats fed the same HFD.
Feeding a HFD increases liver hypoxia
Hypoxia has been implicated as a causative factor in alcohol-
inducedfattyliverdisease[4,5];however,whetherhypoxiaisalso
associated with NAFLD and NASH is not known. The hypoxia
marker pimonidazole was used to determine the extent of liver
hypoxia. Figure 2(A) shows the patterns of pimonidazole adduct
formation (brown) against a haematoxylin nuclear counterstain
(blue) in representative control and HFD livers at 16 weeks.
Under normal conditions the most hypoxic region of the liver
is the pericentral region or zone 3. HFD feeding for 16 weeks
increased pimonidazole binding in zone 3 and extended staining
into the midzonal and periportal regions when compared with
control livers (Figure 2A). Liver hypoxia was also increased by
feeding a HFD for 8 weeks, although to a lesser extent (results
notshown).TheareaofpimonidazolestaininginliversfromHFD
mice was signiﬁcantly increased by 40% over that observed in
controls (Figure 2B). Similarly, a HFD signiﬁcantly increased
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Figure 1 Effect of HFD on liver histology, triacylglycerol measurements and CYP2E1 protein levels
Representative liver sections from mice maintained for 16weeks on control (A,2 0 ×)o raH F D( B,2 0 × and C,4 0 ×). (C) Ballooned hepatocytes (three solid arrows) and Mallory bodies (one
broken arrow) were observed in zone 3 of HFD-fed mouse livers. (D) Quantiﬁcation of liver triacylglycerol content. P =0.07, compared with control at 8 weeks; ∗P <0.05, compared with control at
16weeks.(E)QuantiﬁcationofCYP2E1proteinlevels.RepresentativeWesternblotsfromeachgroupareshownabovethebargraphin(E).LevelsofimmunoreactiveCYP2E1proteinwerenormalized
to total protein run on duplicate gels stained with SyproRuby protein stain (Invitrogen). ∗P <0.05, compared with control at 8weeks; ∗∗P <0.01, compared with control at 8 weeks; ∗∗∗P <0.01,
compared with HFD at 8weeks. (F) Quantiﬁcation of total protein on duplicate protein-stained gels used for CYP2E1 Western blots. Note there were no differences in total protein between control
and HFD groups. Values represent the means+ −S.E.M. for 4–6 pairs of mice.
the intensity of labelled cells compared with controls by approx.
60% (Figure 2C). These results are indicative of increased liver
hypoxia in mice fed a HFD.
Feeding a HFD causes mitochondrial dysfunction
Feeding a HFD resulted in alterations in mitochondrial function
(Figure 3). While respiration was largely unaffected by feeding a
HFDfor8 weeks,state3respirationwassigniﬁcantlydecreasedat
16 weeks with a slight increase in state 4 respiration (Figures 3A
and 3C). This decrease in state 3 respiration translated into a
signiﬁcant decrease in the RCR (Figures 3B and 3D). Moreover,
feeding a HFD for 16 weeks signiﬁcantly decreased complex IV
(cytochrome c oxidase) activity (Figure 3E), whereas complex I
(NADH dehydrogenase) activity (Figure 3F) was unaffected by
feeding a HFD. There was no difference in citrate synthase
activity, a commonly used mitochondrial marker enzyme,
between groups at 16 weeks (control, 0.845+ −0.05 and HFD,
0.804+ −0.027 μmol/min per mg of protein, P=0.39). No change
in citrate synthase activity indicates that the higher levels of
hepatic triacylglycerol in the HFD group had no effect on
the overall content or purity of isolated mitochondria used for
functional assays.
Mitochondrial function was further evaluated by assessing
uncoupledrespiration andthe mitochondrial membrane potential.
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Figure 2 Effect of HFD on liver hypoxia
(A) Representative photomicrographs depicting patterns of pimonidazole adduct formation (brown) against a haematoxylin-nuclear counterstain (blue) in liver sections of mice fed either a control
dietorHFDfor16weeks.IncreasedstainingforthepimonidazoleadductsdemonstratesincreasedtissuehypoxiaintheHFDgroupascomparedwithcontrol.Imageanalysisdemonstratedincreased
area (B)and intensity (C)of pimonidazoleadductsin liver from HFDgroupcomparedwith control.Note: PP, periportalor zone1 region ofliver lobule;PC, pericentralor zone3 regionof liver lobule.
Values represent the means+ −S.E.M. for three pairs of mice. ∗P <0.05, ∗∗P <0.01, compared with control.
At16 weeks,uncoupledrespiration,i.e.respirationinthepresence
of FCCP, was signiﬁcantly decreased in mitochondria from HFD
mice compared with controls (Figure 4A). Feeding a HFD for
16 weeks also decreased the red/green ﬂuorescence ratio of the
membrane potential sensitive dye JC-1, indicating impairment in
the ability of mitochondria to fully develop a membrane potential
(Figure 4B). There was no difference in JC-1 ﬂuorescence
between control and HFD groups when mitochondria were
uncoupled with FCCP, indicating that the HFD-dependent
decrease was not due to inherent differences in mitochondria that
would have affected baseline measurements or uptake of JC-1.
Taken together, these data suggest that feeding a HFD causes
mitochondrial dysfunction at the level of the respiratory chain.
HFD increases the sensitivity of mitochondrial respiration to
inhibition by NO
The effect of a HFD on NO-dependent inhibition of liver
mitochondria respiration was assessed with high-resolution
respirometry. Oxygen traces from a representative experiment are
showninFigure5(A).After mitochondriaandsuccinate/rotenone
were added to the respiration chamber, state 3 respiration was
initiated by the addition of ADP (0.5 mM). When the O2
concentration reached approximately 160 μM (i.e. 80% of the
initial O2 concentration), the NO donor PAPA NONOate (5 μM)
was added to the respiration chamber (Figure 5A). In the absence
of the NO donor, a constant rate of O2 consumption was observed
until O2 was depleted (Figure 5A, dashed lines), whereas addition
oftheNOdonorresultedininhibitionofmitochondrialrespiration
in both control and HFD groups (Figure 5A, solid lines). It
should be pointed out that respiration rates were restored to pre-
NO rates in both groups upon the addition of the NO scav-
enger oxyhaemoglobin (results not shown, and reported in
[16,17]). Additionally, there was no difference in NO production
from PAPA NONOate in mitochondrial suspensions from control
and HFD groups, indicating no difference in NO consumption
between groups (results not shown).
To determine whether there was a difference in the sensitivity
of mitochondrial respiration to inhibition by NO between control
and HFD groups, respiration rate, calculated as the instantaneous
derivative of the O2 concentration versus time traces shown in
Figure5(A),wasplottedasafunctionofNOconcentration,which
was recorded following the bolus addition of PAPA NONOate
with the NO sensor (not shown) (Figure 5B). There was no
signiﬁcant difference in NO-dependent inhibition of respiration
between liver mitochondria from control and HFD groups at
8 weeks (results not shown). In contrast, at 16 weeks there was
a statistically signiﬁcant increase in the degree of NO-dependent
inhibition of respiration in HFD mitochondria compared with
controls (Figure 5B). The NO concentration required to cause a
50% inhibition in respiration (i.e. IC50) fell signiﬁcantly from
0.436+ −0.029 μM in control mitochondria to 0.314+ −0.022 μM
in HFD mitochondria (P=0.04) (Figure 5C).
HFD increases iNOS protein and 3-NT levels in liver
NO-dependent inhibition of respiration has been shown to
increase superoxide (O2
−) production from the respiratory chain
and in turn could lead to greater levels of peroxynitrite (ONOO
−)
formation[26].Thisoxidantcanmodifyproteinsintherespiratory
chain,leadingtodecreasedactivity[27].Interestingly,nitrationof
tyrosine has been reported to be increased in the livers of NASH
patients [28] and ob/ob mice with severe steatosis [29]. Similarly,
iNOS levels are increased in liver of ob/ob mice; however, the
impact of a HFD on hepatic iNOS expression is not known.
While iNOS protein was detected in control livers, signiﬁcantly
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Figure 3 Effect of HFD on respiratory rates, RCR and respiratory complex activities in liver mitochondria
State 3 and 4 respiration was measured and the RCR was determined using either glutamate/malate (A and B)o rs u c c i n a t e( C and D) as oxidizable substrates in freshly isolated mitochondria.
(E) Complex IV activity was measured by monitoring the rate of oxidation of fully reduced cytochrome c at 550nm. (F) Complex I activity was assessed by measuring the rotenone-sensitive rate
of oxidation of NADH initiated by coenzyme Q1. Complex I and IV activities were measured at the 16week feeding time point. Values are expressed as the means+ −S.E.M. for six pairs of mice.
∗P <0.05, ∗∗P <0.01, compared with control.
higher levels of iNOS protein were detected in livers of HFD
mice at 16 weeks (Figure 6). In concert, we examined the effect
of feeding a HFD on 3-NT formation. A small amount of 3-NT
was detected in livers from control animals, whereas there was
signiﬁcant 3-NT staining in the livers of mice fed the HFD for
16 weeks(Figure7A).Boththeareaandintensityof3-NTstaining
were signiﬁcantly increased in response to a HFD compared with
control (Figures 7B and 7C). Interestingly, the gradient of 3-
NT immunoreactivity parallels that observed for the hypoxia
gradientinvivo(Figure2),suggestingalinkbetweenhypoxiaand
increased nitrative stress. Moreover, as predicted, 3-NT levels
were elevated within mitochondrial proteins isolated from livers
of the HFD group compared with controls (Figure 8).
DISCUSSION
Elucidating the speciﬁc molecular mechanisms responsible for
NAFLD and NASH has been slow because of the limitations
associated with existing experimental animal models [30].
Currently, the most widely used models to study NAFLD are
genetically altered rodent models, e.g. the obese ob/ob mouse and
fa/fa rat. While these models, with defects in leptin physiology,
develop severe steatosis, NASH does not occur unless animals
are challenged with endotoxin [31] or fed a methionine/choline-
deﬁcient diet [32]. Similarly, even though wild-type mice fed
a methionine/choline-deﬁcient diet develop histologic markers
of NASH, this model induces an extreme nutritional deﬁciency
not observed in NASH patients, thus limiting mechanistic
comparisons.Toaddressthisproblem,Lieberetal.[21]developed
anexperimentalmodelinwhichratswerefedaHFDthatcontains
71% total calories as fat. Rats fed on this diet for 3 weeks
developed several of the key features of NAFLD, including
steatosis, inﬂammation, and increased CYP2E1 protein levels,
whereas hepatocyte ballooning and Mallory bodies were not
observed.
In the present study, we adapted this long-term HFD feeding
model to C57BL/6 mice to investigate the role of hypoxia and
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Figure 4 Effect of HFD on uncoupler-stimulated respiration and the
membrane potential in liver mitochondria
(A) Oxygen consumption was measured in freshly isolated mitochondria in the presence of
succinate/rotenone (15mM/5μM) and the uncoupler FCCP (1μM). (B) Membrane potential
was reported by the red/green ﬂuorescence ratio of JC-1 in freshly isolated coupled (−FCCP)
and uncoupled (+FCCP) mitochondria. Both uncoupled respiration and membrane potential
are shown for the 16week feeding time point. Values are expressed as the means+ −S.E.M. of
six pairs of mice. ∗P <0.05, compared with control. AU, absorbance units.
bioenergetic defects in the development of NAFLD and NASH.
In the current study, feeding mice a HFD ad libitum produces
macro- and micro-steatosis, hepatocyte ballooning, and Mallory
bodies, which are accompanied by increased liver triacylglycerol
concentrations and CYP2E1 protein levels (Figure 1). It is likely
that feeding a HFD increases CYP2E1 levels in response to
elevated liver concentrations of ketones and fatty acids that serve
as inducers and substrates of P450 enzymes [33]. Importantly,
hepatic CYP2E1 levels are increased in NASH patients [34].
These observations demonstrate that feeding wild-type mice
a HFD reproduces the important histologic and biochemical
features observed in NASH patients, strengthening the rationale
for using a self-administration (i.e. voluntary) dietary feeding
approach to study the molecular mechanisms involved in the
pathogenesis of NAFLD and NASH.
Accompanying these histologic features of NASH were
signiﬁcant defects in mitochondrial function. In the present study,
feedingaHFDfor16 weekssigniﬁcantlydecreasedmitochondrial
state 3 respiration and the RCR. Cytochrome c oxidase activity
and uncoupler-stimulated respiration were also decreased by a
HFD (Figures 3 and 4). These observations suggest that chronic
exposure to a HFD damages mitochondria such that the rate at
which mitochondria synthesize ATP via oxidative phosphoryl-
ation may be depressed, resulting in a bioenergetic defect.
Importantly, our results support reports of decreased respiratory
complex activities in liver biopsy samples taken from NASH
patients compared with normal liver [12]. In contrast, in liver
mitochondria from ob/ob mice, state 3 respiration and respiratory
control are only impaired when substrate is limited to the res-
piratorychain[9].Onthebasisofthis,weproposethatthedietary
approach used in the current study more accurately models the
molecular changes that occur in human disease pathogenesis.
Figure 5 Effect of HFD on NO-dependent inhibition of mitochondrial
respiration
(A)Arepresentativerespirationexperimentusingmitochondria(0.5mg/ml)fromliverofcontrol
(black lines) and HFD (grey lines) mice in the presence of succinate/rotenone (15mM/5 μM)
and ADP (0.5mM). Oxygen traces are shown in the presence of PAPA NONOate (5.0μM, solid
lines), added to the chamber at 80% O2 (at the arrow) and in its absence (dotted lines). Note
that there was no difference in the rate and amount of NO produced between groups (results
not shown). (B) Representative traces of respiration rate, % of maximum, as a function of NO
concentrationusingmitochondriafromliverofcontrol(black)andHFD(grey)mice.BothO2 and
NOconcentrationsaremeasuredsimultaneouslyfortheentiredurationofeachexperimentalrun.
(C) The concentration of NO that causes a 50% decrease in mitochondrial respiration rate (i.e.
IC50) for control and HFD groups is shown. Results obtained from traces shown in (B) (control,
black line, IC50 =solid line and HFD, grey line, IC50 =dashed line). Values are expressed as
the means+ −S.E.M. for six pairs of mice. ∗P <0.05, compared with control.
These new ﬁndings raise an important point with regard to the
needtotranslatewhatappearstobeamodestchangeinrespiratory
chain function to the pathobiology of NASH. While it is apparent
that the mitochondrial depolarization observed in the HFD group
cannot be directly linked to a defect in cytochrome c oxidase,
it is possible that alterations in mitochondrial thresholds of
respiratory chain enzymes occurred in response to the metabolic
stress induced by chronic exposure to a HFD. Speciﬁcally, it
is likely that under conditions of pathological stress, in this
instance NASH, the bioenergetic demands on mitochondria are
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Figure 6 Effect of HFD on iNOS protein levels in liver
(A) Representative photomicrographs demonstrating the extent of iNOS staining (red) against
a DAPI-nuclear counterstain (blue) in liver sections of mice fed either a control or HFD for
16weeks.IncreasedredstainingshowselevatedtissuelevelsofiNOSproteinintheHFDgroup
as compared with the control. Image analysis demonstrated increased intensity (B) of iNOS
staining in liver from HFD groups compared with control. There was no statistically signiﬁcant
difference in the area of iNOS staining between control and HFD groups (results not shown).
Values represent the means+ −S.E.M. for four pairs of mice. ∗P <0.05, compared with control.
increased for repair and detoxiﬁcation, while at the same time
the threshold capacity of the respiratory chain complexes is
limited. In support of this concept, we and others have shown
a similar decrease in state 3 respiration (approximately 25%)
following chronic alcohol consumption, which is associated with
theinabilityofmitochondriatomeettheenergeticdemandsofthe
tissue [15,35]. For example, it has been shown that decreased
activityinrespiratorychaincomplexesresultsinmuchlowerATP
synthesis in the liver [35]. Importantly, this may be connected
directly to pathology because the inability to maintain sufﬁcient
ATP levels has been linked to increased hepatocyte death when
steatotic hepatocytes are placed under low O2 partial pressures
[36]. It is proposed that the same holds true in the present study,
as we observed increased liver injury coupled with hypoxia in
the HFD group. Therefore, when ATP synthesis is depressed this
would increase the susceptibility of hepatocytes to cell death,
especially when ATP needs are increased acutely in the NASH
patient. Moreover, this is important as a loss in the capacity for
maintenance of hepatic ATP levels may ultimately predispose
liver to permanent damage, due to a depression in the anabolic
processes responsible for replacing damaged and/or lost cellular
components.
One consequence of impaired mitochondrial functioning in
the HFD group may be perturbations in the physiological O2
gradient within the liver between the portal and central vein
circulations leading to hypoxia. Speciﬁcally, we postulate that
the inefﬁcient mitochondria damaged by chronic exposure to a
HFD will be required to have increased O2 consumption in vivo
to maintain adequate ATP levels in the liver tissue. Previous
studiesinexperimentalmodelsofalcoholicfattyliverdiseasehave
shown induction of a ‘hypermetabolic state’ and enhanced tissue
hypoxia in response to increased O2 uptake coupled to ethanol
oxidation [37]. By analogy, chronic exposure to a HFD can also
be expected to induce a ‘hypermetabolic state’ in the liver due to
continued delivery of free fatty acids to damaged mitochondria.
As a result of these events, damaged mitochondria and increased
free fatty acid load, the O2 gradient within the liver lobule would
be steepened due to increased mitochondrial O2 consumption in
upstreamperiportalhepatocytes(i.e.O2-richcellssurroundingthe
portal vein), placing the downstream pericentral hepatocytes (i.e.
O2-poor cells surrounding the central vein) under a more severe
degree of hypoxia, as shown in Figure 2.
Figure 7 Effect of HFD on 3-NT levels in liver
(A) Representative photomicrographs depicting patterns of 3-NT staining (brown) against a haematoxylin nuclear counterstain (blue) in liver sections of mice fed either a control diet or HFD for
16weeks. Increased brown staining demonstrates increased tissue 3-NT levels in the HFD group as compared with control. Image analysis demonstrated increased area (B) and intensity (C)o f3 - N T
staining in liver from the HFD group compared with control. Values represent the means+ −S.E.M. for ﬁve pairs of mice. ∗P <0.05, compared with control.
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Figure 8 Effect of HFD on 3-NT levels in liver mitochondrial proteins
(A)RepresentativeWesternblotsdepictingtheextentofnitrationinmitochondrialproteinsfrom
micefedeitheracontrolorHFDfor16weeks.RepresentativeWesternblotsfortwoseparatepairs
ofmiceareshownalongwiththeirduplicatestainedtotalproteingels.(B)Quantiﬁcationof3-NT
levels in mitochondrial proteins. Levels of nitrated proteins were normalized to total protein.
(C) Quantiﬁcation of total protein was performed on duplicate gels, stained with SyproRuby
protein stain, used for 3-NT Western blots. Note there were no differences in total protein
between control and HFD groups. Values represent the means+ −S.E.M. for three pairs of mice.
∗∗P <0.01, compared with control.
An association between hypoxia and steatotic liver injury is
strengthenedbyobservationsofaninversecorrelationbetweenthe
degree of steatosis and blood ﬂow in the hepatic microcirculation
[38].Accordingly,asfataccumulatesinthecytosol,thisincreases
hepatocyte size (i.e. ballooning), which will reduce the size of
the hepatic sinusoid and reduce blood ﬂow, thereby rendering
downstream hepatocytes hypoxic. This scenario is likely in the
present study as ballooned hepatocytes were observed in the liver
from HFD mice. Indeed, several studies have shown that
steatotic livers have a signiﬁcantly reduced tolerance to ischemia-
reperfusion injury following transplantation, which can be linked
to bioenergetic defects and hypoxic stress [39].
Interestingly, the interaction of the signalling molecule NO
withthemitochondrialrespiratorychainhasbeenimplicatedasan
importantphysiologicalindicatorforhowcellsrespondtohypoxic
stress [19,40]. Speciﬁcally, NO reversibly inhibits mitochondrial
respiration at cytochrome c oxidase via competition with O2 at
the haem-binuclear center of the enzyme [41,42]. It has been
proposed that one function of this ‘NO-cytochrome c oxidase
signalling’ interaction is to regulate O2 gradients within cells
and tissues via limiting O2 consumption in actively respiring
mitochondria [43]. Theoretically, this would have the effect of
extending O2 gradients within tissues and preventing hypoxia. In
thepresentstudy,weobservedthatNOwasamorepotentinhibitor
of respiration in mitochondria isolated from livers of HFD-fed
animals as compared with controls. Mitochondria isolated from
HFD mice required 25% less NO to obtain 50% inhibition
of respiration compared with the control group (Figure 5),
which is consistent with our previous studies in the alcohol
hepatotoxicity model [16,17]. On the basis of this, one might
predict that this increased sensitivity of mitochondrial respiration
to inhibition by NO would lead to increased local O2 partial
pressure and concomitantly decreased hypoxia due to inhibition
of mitochondrial O2 consumption. However, we did not observe
this, but found enhanced hypoxia in the pericentral region of
liverfromHFD-fedanimals,presumablyinresponsetodecreased
mitochondrial efﬁciency in damaged mitochondria.
One possible explanation for the inability of increased NO
sensitivity of mitochondria to attenuate liver hypoxia during
pathological states could be related to induction of additional NO
targets or ‘sinks’ in hepatocytes, such that NO is unable to target
mitochondria and inhibit respiration even though the intrinsic
sensitivity of mitochondrial respiration to inhibition by NO is
increased by chronic exposure to a HFD. For example, increased
free fatty acid delivery to mitochondria is predicted to increase
O2 consumptionandstimulatesO2
− productionasaconsequence
of increased reduction of the respiratory chain complexes [44].
Accordingly,increasedformationofO2
− inresponsetoincreased
fatty acid load, impaired electron transport, and/or increased
CYP2E1 in the HFD group would effectively decrease free NO
concentrations in the cell via enhanced formation of ONOO
−,
as shown by increased 3-NT in whole liver and within the
mitochondrial compartment. This may be especially pertinent,
as the distribution of 3-NT paralleled that of hypoxia in the
pericentralregionoftheliver.ErusalimskyandMoncada[18]have
also suggested that one consequence of NO-mediated inhibition
of respiration is to divert O2 to non-mitochondrial O2-requiring
targets, which themselves could be increased in response to
hypoxiaand/orotherpathologicalconditions.Onepotentialtarget
for NO and O2 may be CYP2E1, which was induced by a HFD
and known to be localized to the pericentral zone of the liver. The
interaction of NO with CYPs (cytochrome P450s) would result in
decreasedfreeNOconcentrationsandessentiallyblocktheability
of NO to increase local O2 partial pressure in vivo. This concept
is supported by studies demonstrating that L-arginine infusion
improves hepatic microcirculation and oxyhaemoglobin status,
whereas these parameters are worsened in steatotic liver when
NO production is blocked by infusion of the nitric oxide synthase
inhibitor N
G-nitro-L-arginine methyl ester [38].
Another issue of relevance to this study concerns the O2 partial
pressure dependence of O2
− and NO production in tissues
invivo,especiallyduringhypoxia.Recentstudieshaveshownthat
ROS/RNS generation is O2 dependent [45,46], but it is important
to note that O2 is present under conditions of hypoxia and that
nitrationmechanismscanarisefromO2-independentmechanisms
such as the metabolism of nitrite by peroxidases [47]. There
have been a number of measurements of protein modiﬁcation
of ROS/RNS under conditions associated with hypoxia, which
can be linked to not only the generation of reactive species
but also stability and turnover of the protein adducts [48,49].
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This concept is based on the view that there is a combination
of effects that lead to the accumulation of post-translationally
modiﬁed proteins by ROS/RNS-dependent mechanisms, which is
supported by the present study. The key events that contribute to
the accumulation of modiﬁed proteins are the increased localized
production of ROS in the mitochondrion, which is enhanced as
the respiratory chain complexes become more reduced and when
tissue oxygenation decreases. Similarly, another critical aspect
to this is that many of the ROS/RNS-metabolizing enzymes or
processes are energy requiring, and their efﬁciency will therefore
be decreased during hypoxia. Finally, the repair mechanisms that
either remove speciﬁc modiﬁcations such as nitration or process
damaged proteins are also energy requiring. Taken together, this
combination of effects is predicted to result in a higher rate
of formation of oxidized/modiﬁed proteins and a lower rate of
protein turnover.
Insummary,previousstudieshaveproposedthattheinteraction
of NO with cytochrome c oxidase is a regulated and physio-
logically relevant pathway that functions to control ROS
formation for redox signalling and maintain O2 gradients in
tissues [19]. However, during pathologic conditions, such as
NAFLD and NASH, a loss in control of this pathway occurs
in response to impaired mitochondrial function. We propose that
while NO-dependent inhibition of respiration may be an adaptive
and protective mechanism in healthy tissues under normoxic or
mildly hypoxic conditions, this function of NO is maladaptive
in pathologic conditions associated with damaged mitochondria
and/or low O2 concentrations. Speciﬁcally, damaged mitochon-
dria exposed to low O2 will be under a greater reductive stress
and it is under these conditions that the interaction of NO
with mitochondria may be pathologic, because ROS and RNS
formation is enhanced and ATP production is compromised [19].
Therefore, we propose that there is a failure in the ability of NO
to regulate respiration in vivo when mitochondria are damaged,
which results in a dysregulation of O2 gradients in steatotic
liver. The consequence of this is enhanced hypoxia that, when
coupled with mitochondrial dysfunction, may place hepatocytes
under bioenergetic and reductive stress, which contributes to the
pathogenesis of liver disease in the NASH patient.
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